We are live on ! Find out more
GOVX icon

GeoVax Labs

21 hedge funds and large institutions have $3.39M invested in GeoVax Labs in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 3

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

68% more capital invested

Capital invested by funds: $2.02M → $3.39M (+$1.37M)

17% more funds holding

Funds holding: 18 → 21 (+3)

2.73% more ownership

Funds ownership: 9.85% → 12.58% (+2.7%)

Holders
21
Holders Change
+3
Holders Change %
+16.67%
% of All Funds
0.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
9
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

GOVX Hedge Fund Activity: Q3 2022 in Review

21 of the 5,829 institutional investors tracked by Wall St. Rank reported a position in GeoVax Labs (GOVX) for Q3 2022, worth a combined $3.39M — up 68% from $2.02M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new GOVX positions and 3 closed out — a net gain of 3 holders — while 9 added to existing stakes and 3 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $990K. The largest seller was Armistice Capital, exiting entirely with an estimated $1.13M sold.

  • 21 institutional investors held GeoVax Labs (GOVX) as of Q3 2022, up from 18 in Q2 2022.
  • Funds reported $3.39M of GeoVax Labs stock for Q3 2022, up 68% quarter-over-quarter.
  • 6 funds opened new GeoVax Labs positions in Q3 2022 and 3 closed out, a net change of +3 holders.
  • The largest GeoVax Labs buyer in Q3 2022 was Renaissance Technologies, an estimated $990K added.
  • The largest GeoVax Labs seller in Q3 2022 was Armistice Capital, an estimated $1.13M sold.

Based on aggregated 13F filings for Q3 2022.